Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Barriers and facilitators to cervical cancer screening among under- and neverscreened women in Flanders, Belgium - a qualitative study on community and healthcare providers' perspectives.

Autor: Verberckmoes B; International Centre for Reproductive Health (ICRH), Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Corneel Heymanslaan 10, Ghent, 9000, Belgium. bo.verberckmoes@ugent.be.; Department of Obstetrics and Gynaecology, Ghent University Hospital, Corneel Heymanslaan 10, Ghent, 9000, Belgium. bo.verberckmoes@ugent.be., De Paepe E; International Centre for Reproductive Health (ICRH), Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Corneel Heymanslaan 10, Ghent, 9000, Belgium., De Vestele J; International Centre for Reproductive Health (ICRH), Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Corneel Heymanslaan 10, Ghent, 9000, Belgium., Gama A; NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Centre, CHRC, NOVA University Lisbon, Campo Mártires da Pátria 130, Lisbon, 1169-056, Portugal., Keygnaert I; International Centre for Reproductive Health (ICRH), Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Corneel Heymanslaan 10, Ghent, 9000, Belgium., Vermandere H; International Centre for Reproductive Health (ICRH), Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Corneel Heymanslaan 10, Ghent, 9000, Belgium., Degomme O; International Centre for Reproductive Health (ICRH), Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Corneel Heymanslaan 10, Ghent, 9000, Belgium.

Publikováno v: BMC public health [BMC Public Health] 2024 Oct 18; Vol. 24 (1), pp. 2870. Date of Electronic Publication: 2024 Oct 18.

Evaluating the Screening and Enrollment of People at Risk of HIV in Mexico's Preexposure Prophylaxis Demonstration Project, 2018-2020.

Autor: Vermandere H; Center for Evaluation Research and Surveys, National Institute of Public Health of Mexico, Cuernavaca, México., Martínez-Silva G; Center for Evaluation Research and Surveys, National Institute of Public Health of Mexico, Cuernavaca, México., Aguilera-Mijares S; Center for Evaluation Research and Surveys, National Institute of Public Health of Mexico, Cuernavaca, México., Martínez-Dávalos A; Center for Evaluation Research and Surveys, National Institute of Public Health of Mexico, Cuernavaca, México., Bautista-Arredondo S; Center for Evaluation Research and Surveys, National Institute of Public Health of Mexico, Cuernavaca, México.

Publikováno v: Public health reports (Washington, D.C. : 1974) [Public Health Rep] 2024 Sep-Oct; Vol. 139 (5), pp. 606-614. Date of Electronic Publication: 2024 Mar 15.

How the COVID-19 pandemic and the health system's response reduced HIV testing and increased late diagnoses in Mexico.

Autor: Macías-González F; Center for Evaluation Research and Surveys, National Institute of Public Health, Mexico., Vermandere H; Center for Evaluation Research and Surveys, National Institute of Public Health, Mexico., Piñeirúa-Menendez A; CISIDAT, Health Research Consortium, Mexico., Bautista-Arredondo S; Center for Evaluation Research and Surveys, National Institute of Public Health, Mexico.

Publikováno v: AIDS (London, England) [AIDS] 2024 Jun 01; Vol. 38 (7), pp. 1067-1072. Date of Electronic Publication: 2024 Jan 08.

Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples.

Autor: Bell M; International Center for Reproductive Health, Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.; Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Verberckmoes B; International Center for Reproductive Health, Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.; Department of Obstetrics and Gynecology, Ghent University Hospital, Ghent, Belgium., Devolder J; International Center for Reproductive Health, Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.; Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Vermandere H; International Center for Reproductive Health, Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Degomme O; International Center for Reproductive Health, Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Guimarães YM; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil., Godoy LR; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil., Ambrosino E; Institute for Public Health Genomics, Department of Genetics and Cell Biology, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands., Cools P; Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Padalko E; Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.; Department of Medical Microbiology, Ghent University Hospital, Ghent, Belgium.

Publikováno v: Microbiology spectrum [Microbiol Spectr] 2023 Aug 17; Vol. 11 (4), pp. e0008123. Date of Electronic Publication: 2023 Jun 07.